Updates

Axon supports pharmaceutical companies in licensing their products across Europe and beyond. We draft and negotiate licence agreements tailored to each market, helping clients maximise the value of their intellectual property.

We have advised a company on defending itself against an enforcement action brought by the Netherlands Food and Consumer Product Safety Authority (NVWA).

A Nordic company owns a proprietary technology for producing legume-based meat alternatives. Axon drafted technology licensing agreements and developed an IP strategy covering patents and trade secrets, with practical checklists for implementation.

Axon assisted a start-up developing a real-time diagnostic test to define pathogens food. We negotiated and drafted an agreement with a university to support the further development & validation of the technology.

Axon assists medical technology companies in structuring their collaborations with hospitals and universities. We draft and negotiate cooperation agreements that protect our clients’ IP while fostering innovation.

Axon drafted a cooperation agreement between an agro crop improvement company and four other companies, being both shareholders and competitors at the same time.

We have assisted several clients in challenging tender decisions by Dutch hospitals.

We negotiate numerous commercial contracts for our clients, including sale, distribution and agency agreements, or support them in doing so with in-depth feedback and negotiation strategy.

Our firm is experienced in the conduct and defence of companies against freedom of information cases pertaining to confidential under Dutch and EU law, and has defended a number of companies, including a multinational, in a series of such cases over the years.

One of our lawyers has acted as arbiter in international proceedings on MDR compliance.